Responsible screening provides an unprecedented opportunity to study lung cancer at its earliest and even pre-cancerous stages. We work with thought leaders, screening implementers, patients and other stakeholders to ensure the acceleration of research in prevention, screening and early detection. The establishment of the Screening Centers of Excellence network leads naturally to the development of a consortium of sites that work with us along with academic, nonprofit, and corporate partners as a dedicated Lung Cancer Research Network. This network allows us to:
- Conduct implementation research, including related services such as shared decision-making consultations and smoking cessation.
- Improve understanding of risk prediction to determine who should be screened and how often.
- Identify clinically-relevant new technology including improved imaging and use of biomarkers to improve early detection and earlier understandings of the disease.
- Understand the impact of detection of other diseases during lung cancer screening.